Amgen (AMGN) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to -$23.8 billion.
- Amgen's Retained Earnings rose 677.63% to -$23.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.8 billion, marking a year-over-year increase of 677.63%. This contributed to the annual value of -$27.6 billion for FY2024, which is 392.11% down from last year.
- As of Q3 2025, Amgen's Retained Earnings stood at -$23.8 billion, which was up 677.63% from -$25.7 billion recorded in Q2 2025.
- In the past 5 years, Amgen's Retained Earnings ranged from a high of -$21.6 billion in Q1 2021 and a low of -$29.6 billion during Q1 2022
- For the 5-year period, Amgen's Retained Earnings averaged around -$26.1 billion, with its median value being -$26.5 billion (2023).
- Per our database at Business Quant, Amgen's Retained Earnings crashed by 3664.22% in 2022 and then soared by 1102.76% in 2023.
- Amgen's Retained Earnings (Quarter) stood at -$24.6 billion in 2021, then dropped by 16.35% to -$28.6 billion in 2022, then increased by 7.24% to -$26.5 billion in 2023, then decreased by 3.92% to -$27.6 billion in 2024, then grew by 13.74% to -$23.8 billion in 2025.
- Its last three reported values are -$23.8 billion in Q3 2025, -$25.7 billion for Q2 2025, and -$27.1 billion during Q1 2025.